A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis.
about
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspectiveCost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinentDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Oral miltefosine for the treatment of Indian visceral leishmaniasis.Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, IndiaSingle-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 studySpecies-directed therapy for leishmaniasis in returning travellers: a comprehensive guideThe lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in miceA controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India.Therapeutic options for visceral leishmaniasis.The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis.Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda.A new nanoemulsion formulation improves antileishmanial activity and reduces toxicity of amphotericin B.Cedrus deodara: In vitro antileishmanial efficacy & immumomodulatory activity.
P2860
Q28073426-7B72BFA3-6763-4D96-9144-E837EAB4241AQ28475431-1AEEF51A-EB4E-409D-8AB8-65C5072D7EE4Q30275257-110466F1-9B4F-4F2D-8369-CE48E8278479Q34531203-86AA2C6A-EB63-44E6-9BB0-2FF71D193C6BQ35031888-079E88C2-04D0-4A97-8011-246ADE65523FQ35150268-C44C32C8-E771-4F87-8624-1C9700FCD767Q35160905-3217DD02-72B4-4B98-B1E8-C5ADB432B796Q36379560-27380949-617C-4105-A4DE-8A0DBFD7A348Q37230269-8E6187CA-042F-4465-90BE-90D76F1DF813Q37333942-4858274C-8ABE-4563-B63B-B0CE9E946FA1Q37425218-9D1C5FEB-7A1F-4239-BFA1-7B943FAC6236Q38876841-18B84F88-5770-4220-A714-202743E59313Q50084493-5834C603-35DF-4486-B565-CA944414374FQ52583519-C0DD6E52-4D0D-4BEB-9E38-7351C077B412
P2860
A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A comparative evaluation of am ...... Indian visceral leishmaniasis.
@en
A comparative evaluation of am ...... Indian visceral leishmaniasis.
@nl
type
label
A comparative evaluation of am ...... Indian visceral leishmaniasis.
@en
A comparative evaluation of am ...... Indian visceral leishmaniasis.
@nl
prefLabel
A comparative evaluation of am ...... Indian visceral leishmaniasis.
@en
A comparative evaluation of am ...... Indian visceral leishmaniasis.
@nl
P2860
P1476
A comparative evaluation of am ...... Indian visceral leishmaniasis.
@en
P2093
P2860
P304
P356
10.1179/000349804225003154
P577
2004-03-01T00:00:00Z